Chengdu Easton Bio Pharmaceuticals Co., Ltd. logo

Chengdu Easton Bio Pharmaceuticals Co., Ltd. (688513)

Market Closed
11 Aug, 06:57
SSE SSE
¥
50. 11
+2.11
+4.3958%
¥
5.48B Market Cap
- P/E Ratio
2.32% Div Yield
4.36M Volume
- Eps
¥ 48
Previous Close
Add Transaction
Day Range
47.3 52.12
Year Range
40.25 80.48
Want to track 688513 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688513 closed today higher at ¥50.11, an increase of 4.3958% from yesterday's close, completing a monthly increase of 13.371% or ¥5.91. Over the past 12 months, 688513 stock lost -19.2165%.
688513 pays dividends to its shareholders, with the most recent payment made on Jun 02, 2026. The next estimated payment will be in In 9 months on Jun 02, 2027 for a total of ¥0.49.
The last earnings report, released on May 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Chengdu Easton Bio Pharmaceuticals Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jul 01, 2024.
The company's stock is traded on one exchange.

688513 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Chengdu Easton Bio Pharmaceuticals Co., Ltd. (688513) FAQ

What is the stock price today?

The current price is ¥50.11.

On which exchange is it traded?

Chengdu Easton Bio Pharmaceuticals Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688513.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.32%.

What is its market cap?

As of today, the market cap is 5.48B.

Has Chengdu Easton Bio Pharmaceuticals Co., Ltd. ever had a stock split?

Chengdu Easton Bio Pharmaceuticals Co., Ltd. had 1 splits and the recent split was on Jul 01, 2024.

Chengdu Easton Bio Pharmaceuticals Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Mingxu Yuan CEO
SSE Exchange
CNE100004397 ISIN
CN Country
1,400 Employees
2 Jun 2026 Last Dividend
1 Jul 2024 Last Split
- IPO Date

Overview

Chengdu Easton Biopharmaceuticals Co., Ltd. is a renowned entity in the pharmaceutical sector, founded in 2009 and headquartered in Chengdu, China. The company is deeply involved in the research, development, manufacture, and commercialization of pharmaceutical products. With a focus on innovation and quality, Chengdu Easton Biopharmaceuticals Co., Ltd. aims to contribute significantly to the health and well-being of people by providing effective medical solutions across various therapeutic fields. Their operations encompass a wide range of pharmaceutical formulations, catering to critical areas of healthcare including anesthetic/analgesics, cardiovascular, oncology, pediatrics, among others, thereby positioning the company as a key player in the pharmaceutical industry.

Products and Services

  • Finished Dosage Forms

    The company specializes in the production and distribution of finished dosage forms, catering to a variety of therapeutic fields. These include:

    • Anesthetic/Analgesics: These products are designed to alleviate pain and are utilized in both surgical and non-surgical treatments.
    • Cardiovascular: Medications aimed at treating heart diseases and related conditions, supporting heart health and function.
    • Oncology: A range of products focused on combating cancer through various therapeutic approaches.
    • Pediatrics: Medicines formulated specifically for children, addressing a wide spectrum of pediatric health concerns.
    • Other Therapeutic Fields: The company also ventures into other areas, expanding its reach in the healthcare sector to meet diverse medical needs.
  • Active Pharmaceutical Ingredients (APIs)

    Chengdu Easton Biopharmaceuticals Co., Ltd. is also a prominent supplier of high-quality active pharmaceutical ingredients (APIs), which are pivotal in drug manufacturing. The categories include:

    • Oncology: APIs used for creating cancer-fighting drugs.
    • Cardiovascular: Key ingredients for medicines targeting heart diseases and circulatory system disorders.
    • Anesthetic/Analgesics: Essential components for developing pain relief medications.
    • Anti-inflammatory: Substances aimed at reducing inflammation in the body.
    • Gastrointestinal: APIs focused on treating various digestive system disorders.
    • Antiemetic: Ingredients used in making drugs that prevent vomiting and nausea.
    • Neurology/Psychiatry: Chemicals for the treatment of neurological and psychiatric disorders.
    • Urinary System: APIs for medicines targeting urinary tract infections and other related conditions.

Contact Information

Address: No. 8, Ankang Road, Chengdu, China, 610200
Phone: 86 28 8782 7187